发明申请
- 专利标题： Morphinan Compounds
-
申请号： US15839387申请日： 2017-12-12
-
公开(公告)号： US20180327809A1公开(公告)日： 2018-11-15
- 发明人: Roger Tung
- 申请人： Concert Pharmaceuticals, Inc.
- 申请人地址： US MA Lexington
- 专利权人： Concert Pharmaceuticals, Inc.
- 当前专利权人： Concert Pharmaceuticals, Inc.
- 当前专利权人地址： US MA Lexington
- 主分类号： C12Q1/28
- IPC分类号： C12Q1/28 ; G01N33/493 ; G01N33/49 ; A61K31/49 ; A61K31/195 ; C07B59/00 ; C07D471/08 ; A61K31/485 ; A61K31/4709 ; C07D221/28
摘要：
This disclosure relates to novel morphinan compounds and their derivatives, pharmaceutically acceptable salts, solvates, and hydrates thereof. This disclosure also provides compositions comprising a compound of this disclosure and the use of such compositions in methods of treating diseases and conditions that are beneficially treated by administering a σi receptor agonist that also has NMDA antagonist activity.
信息查询
